LSE • SVNS • GB00BMD1Z199
Generating your data highlights...
9.49m USD | # 4177 in GB
27.43m shares | 46.47k USD
6.81b
75.12% | 5.11b
Solvonis Therapeutics (LSE: SVNS) has a market capitalization of $9.49M. Last close 0.11 GBp (as of 2026-10-20); 52-week range 0.1 GBp to 0.36 GBp.